Following these proceedings, Noble Capital Markets initiated its Tonix Pharmaceuticals Holding Corp [TNXP] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including ROTH Capital’s analysts, who increased its forecast for the stock in mid April from “a Neutral” to “a Buy”. ROTH Capital also remained covering TNXP and has increased its forecast on August 18, 2017 with a “Buy” recommendation from previously “Neutral” rating. ROTH Capital revised its rating on September 07, 2016. It rated TNXP as “a Neutral” which previously was an “a Buy”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance Review of TNXP
On Tuesday, Tonix Pharmaceuticals Holding Corp [NASDAQ:TNXP] saw its stock jump 4.91% to $0.20. Over the last five days, the stock has gained 6.27%. Tonix Pharmaceuticals Holding Corp shares have fallen nearly -98.48% since the year began. Nevertheless, the stocks have fallen -98.46% over the past one year. While a 52-week high of $22.14 was reached on 01/02/24, a 52-week low of $0.12 was recorded on 10/03/24. SMA at 50 days reached $0.1607, while 200 days put it at $2.8670.
Levels Of Support And Resistance For TNXP Stock
The 24-hour chart illustrates a support level at 0.1831, which if violated will result in even more drops to 0.1696. On the upside, there is a resistance level at 0.2085. A further resistance level may holdings at 0.2204. The Relative Strength Index (RSI) on the 14-day chart is 61.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0014, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.04%. Stochastics %K at 36.00% indicates the stock is a holding.
How much short interest is there in Tonix Pharmaceuticals Holding Corp?
A steep rise in short interest was recorded in Tonix Pharmaceuticals Holding Corp stocks on 2024-10-31, dropping by -0.62 million shares to a total of 7.67 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 8.29 million shares. There was a decline of -8.1%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 17, 2016 when Oppenheimer resumed its ‘”an Outperform”‘ rating for the stock and retained the price target to $10.
